TERT and glioblastoma: In 2021, the incorporation of telomerase reverse transcriptase (TERT) promoter genetic alterations into the diagnostic classification of GBM within the central nervous system brain tumor taxonomy has provided novel genetic insights that facilitate precise categorization and characterization of these tumors (Gritsch et al., 2022; Kurokawa et al., 2022).